Nevro Receives FDA Approval to Initiate U.S. Randomized Pivotal Trial of Innovative Chronic Pain Treatment

Nevro announced that the FDA has granted approval for initiation of its SENZA-RCT study evaluating the safety and efficacy of Nevro’s high-frequency spinal cord stimulation system for the treatment of chronic pain.
SYS-CON Media